A Study Which Looks at the Quality of Life of Bladder Cancer Patients Receiving Routine Radiation and Chemotherapy
Chemoradiation, a combination of chemotherapy and radiation, is a standard of care approach for the definitive treatment of patients with newly diagnosed muscle-invasive bladder cancer and to preserve the bladder.
This study will assess constitutional, gastrointestinal, and genito-urinary toxicities using validated quality of life questionnaires. Detailed knowledge of these matters will better inform future patients and physicians as to how well patients tolerate these treatments, and allow for a better comparison with surgical approach for bladder cancer.
Patients with muscle-invasive bladder cancer being treated at UCLA with routine chemoradiotherapy will be asked to complete Quality of Life (QOL) questionnaires regarding urinary, bowel and sexual function prior to radiation treatments, and at each follow-up visit after radiation treatment.
Patients are expected to participate in follow-up for a minimum of 3 years and will be encouraged to continue follow-up for up to 5 years.
For More Detailed Information Contact: